2023 saw the Nobel Prize awarded to mRNA technology, reinvigorating the field and spurring a new wave of candidates entering the clinic. The industry has made tremendous strides in applying mRNA technology beyond COVID-19, and as mRNA unlocks the rare, infectious and oncological spaces, the 4th mRNA-Based Therapeutics Summit cements its position as the world's largest, end-to-end mRNA conference, bringing you exclusive scientific and strategic insights from the biggest players across indications and modalities.

Join 400+ mRNA experts and enthusiasts to hear previously-unseen data insights from 65+ world-class speakers from the likes of CureVac, Moderna, BioNTech and Sanofi, and gain exclusive regulatory insights from the FDA, MHRA and EMA.

Personalize your experience and select which sessions best apply to you, by navigating through 4 tracks of content catering to discovery, translation, clinical development and chemistry, manufacturing and controls. Join interactive roundtables and a CEOs’ Panel Discussion, choose from the Regulatory Affairs Strategy or Next Generation mRNA Delivery focus days, and forge meaningful connections in the dedicated networking sessions.

Event Link here.